Results 41 to 50 of about 17,492 (243)

Antineutrophil Cytoplasmic Antibodies and Infection

open access: yesAutoimmunity, 1993
(1993). Antineutrophil Cytoplasmic Antibodies and Infection. Autoimmunity: Vol. 15, No. 1, pp. 81-83.
J M, Durand   +7 more
openaire   +2 more sources

Antineutrophil Cytoplasmic Antibody–Associated Active Scleritis [PDF]

open access: yesArchives of Ophthalmology, 2008
To determine whether antineutrophil cytoplasmic antibody (ANCA) testing provides prognostic information in evaluating scleritis.Retrospective medical record review of patients evaluated at a tertiary care center from January 1, 1995, to June 30, 2006, was performed to compare clinical features, treatments, and associated systemic disease in patients ...
Lani T, Hoang   +4 more
openaire   +2 more sources

Medial medullary infarction caused by antineutrophil cytoplasmic antibody-related vasculitis: Case report and review of the literature [PDF]

open access: yes, 2017
Rationale: Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Patient concerns: We report the case of a 76-
Ishii Kazuhiro   +7 more
core   +2 more sources

Applications and challenges of glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis

open access: yesLinchuang shenzangbing zazhi, 2022
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis are a diverse group of systemic autoimmune disorders characterized by the presence of ANCA in sera, involving frequently kidney and lung.
Wen Kai-lian, Li Gui-sen, Wang Li
doaj  

An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report [PDF]

open access: yes, 2014
INTRODUCTION: Eosinophilic granulomatosis with polyangiitis is a rare and potentially fatal disease if not readily diagnosed. Cerebral involvement is extremely rare and clinical presentation as hemorrhagic stroke is even rarer.
Andolina, G   +5 more
core   +2 more sources

Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This graphical abstract summarizes our study in which we established a novel murine model of antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis. Neutrophil recruitment was induced using thioglycolate, followed by timed administration of propylthiouracil and phorbol 12‐myristate 13‐acetate to generate DNase I‐resistant neutrophil ...
Sakiko Masuda   +9 more
wiley   +1 more source

ANCA-positive vasculitis: Clinical implications of ANCA types and titers [PDF]

open access: yes, 2016
INTRODUCTION: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disease that can affect multiple organs, the kidney being one of the most affected.
Domingues, V., Machado, B., Santos, J.
core   +1 more source

Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis

open access: yesArthritis &Rheumatology, EarlyView.
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Carbimazole-induced agranulocytosis – A rare case report

open access: yesJournal of Dr. NTR University of Health Sciences, 2018
A 30-year-old lady with hyperthyroidism for the past 1 year was initially on carbimazole 30 mg twice orally and then changed to 30 mg once daily.
R Siddeswari, Sikandar Mohan, K Swamy
doaj   +1 more source

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome [PDF]

open access: yes, 2018
Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from
Aeddula, Narothama Reddy   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy